Triple drug combination promising to treat breast cancer
Triple drug combination is promising option to treat metastatic HER2+ breast cancer – Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.